2.62

4.73% -0.13

Pre-market: 2.69 0.07 +2.67%

Cassava Sciences Inc (SAVA)

Overview News Price History Option Chain Financials Why SAVA Down? Discussions Forecast Stock Split Dividend History

Cassava Sciences Inc stock is traded at $2.62, with a volume of 1.55M. It is down -4.73% in the last 24 hours and up +11.49% over the past month. Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.

Previous Close:

$2.75

Open:

$2.75

24h Volume:

1.55M

Relative Volume:

0.29

Market Cap:

$126.05M

Revenue:

Net Income/Loss:

$-97.22M

P/E Ratio:

-1.8986

EPS:

-1.38

Net Cash Flow:

$-82.44M

1W Performance:

+0.38%

1M Performance:

+11.49%

6M Performance:

-74.01%

1Y Performance:

-90.07%

1-Day Range:

$2.61

$2.77

1-Week Range:

$2.61

$2.83

52-Week Range:

$2.23

$42.20

Cassava Sciences Inc Stock (SAVA) Company Profile

Name

Cassava Sciences Inc

Sector

Healthcare (1176)

Industry

Biotechnology (685)

Phone

512-501-2444

Address

6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

SAVA's Discussions on Twitter

Compare SAVA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SAVA Cassava Sciences Inc	2.62	126.05M	0	-97.22M	-82.44M	-1.38
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-26-24	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-08-24	Upgrade	H.C. Wainwright	Neutral → Buy
Jul-01-24	Downgrade	H.C. Wainwright	Buy → Neutral
Nov-16-22	Downgrade	B. Riley Securities	Buy → Neutral
Jul-15-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jul-07-21	Reiterated	Maxim Group	Buy
Apr-27-21	Initiated	B. Riley Securities	Buy
Feb-16-21	Reiterated	H.C. Wainwright	Buy
Oct-23-20	Initiated	Cantor Fitzgerald	Overweight
Sep-23-20	Upgrade	H.C. Wainwright	Neutral → Buy
May-18-20	Downgrade	H.C. Wainwright	Buy → Neutral
May-15-20	Downgrade	Maxim Group	Buy → Hold
Jan-10-20	Reiterated	Maxim Group	Buy

View All

Cassava Sciences Inc Stock (SAVA) Latest News

Jan 21, 2025

CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. – SAVA - GlobeNewswire Inc.

Jan 21, 2025

SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit - PR Newswire

Jan 21, 2025

Cassava Sciences, Inc. Investors: February 10, 2025 Filing Deadline in Securities Class Action - GlobeNewswire Inc.

Jan 21, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesSAVA - PR Newswire

Jan 21, 2025

CASSAVA SCIENCES, INC. (NASDAQ: SAVA) DEADLINE ALERT: - GlobeNewswire

Jan 21, 2025

Jan 20, 2025

2025-01-20 | Class Action Filed Against Cassava Sciences, Inc. (SAVA)February 10, 2025 Deadline to JoinContact Levi & Korsinsky | NDAQ:SAVA | Press Release - Stockhouse Publishing

Jan 20, 2025

Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire

Jan 20, 2025

Jan 19, 2025

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jan 19, 2025

2025-01-19 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. LawsuitSAVA | NDAQ:SAVA | Press Release - Stockhouse Publishing

Jan 19, 2025

Jan 17, 2025

CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassav - PR Newswire

Jan 17, 2025

2025-01-17 | Cassava Sciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA | NDAQ:SAVA | Press Release - Stockhouse Publishing

Jan 17, 2025

Jan 16, 2025

CASSAVA SCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire

Jan 16, 2025

Class Action Filed Against Cassava Sciences, Inc. (SAVA) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire

Jan 16, 2025

Simufilam’s Collapse Leaves Cassava Searching For A Viable Future (NASDAQ:SAVA) - Seeking Alpha

Jan 15, 2025

Jan 14, 2025

CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA - GlobeNewswire

Jan 14, 2025

Jan 13, 2025

Investors in Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - AccessWire

Jan 13, 2025

Shareholders that Lost Money on Cassava Sciences, Inc. (SAVA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - AccessWire

Jan 13, 2025

Investors in Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your Rights – SAVA - AccessWire

Jan 13, 2025

SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Jan 13, 2025

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces - WICZ

Jan 13, 2025

CASSAVA SCIENCES, INC. (NASDAQ: SAVA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cassava Sciences, Inc. Investors of Upcoming Deadline - WICZ

Jan 13, 2025

Cassava Sciences, Inc. Sued for Securities Law Violations – - GlobeNewswire

Jan 13, 2025

Jan 12, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. LawsuitSAVA - AccessWire

Jan 12, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - Stockhouse Publishing

Jan 12, 2025

SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Jan 12, 2025

Jan 11, 2025

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Cassava - GlobeNewswire

Jan 11, 2025

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure - The Bakersfield Californian

Jan 11, 2025

Jan 10, 2025

Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - AccessWire

Jan 10, 2025

SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Jan 10, 2025

Lost Money on Cassava Sciences, Inc. (SAVA)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - AccessWire

Jan 10, 2025

Shareholders that lost money on Cassava Sciences, Inc. (SAVA) should contact Levi & Korsinsky about pending Class ActionSAVA - AccessWire

Jan 10, 2025

Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the - GuruFocus.com

Jan 10, 2025

Jan 09, 2025